NHSX

NHS Artificial Intelligence provider reports 160% growth, promising to transform healthcare with better data

Wednesday, September 15, 2021 - 4:59pm

LONDON, Sept. 15, 2021 /PRNewswire/ -- RwHealth , the leading provider of Artificial Intelligenceto the healthcare industry, has reported 160%year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and pharmaceutical companies.

Key Points: 
  • LONDON, Sept. 15, 2021 /PRNewswire/ -- RwHealth , the leading provider of Artificial Intelligenceto the healthcare industry, has reported 160%year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and pharmaceutical companies.
  • RwHealth's Data Science Platform combines Artificial Intelligence (AI)andMachine Learning to give healthcare providers in-depth data to make better decisions and improve patient outcomes.
  • By using RwHealth's analytical capabilitiesto make predictions, model treatment options, improve safety and increase efficiency, clinicians can deliver better, more widespread care.
  • In September 2020, NHSX , the organisation driving digital transformation inhealth and social care, announced a 250m investment into AI in UK healthcare.

NHS Deploys TytoCare's Telehealth Solution to 14 Trusts across the UK as part of Virtual Wards Project

Tuesday, September 14, 2021 - 2:53pm

NEW YORK, Sept. 14, 2021 /PRNewswire/ -- TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, today announced its expanded partnership with the NHS that will see the deployment of TytoCare's telehealth solution across 14 organisations and 26 projects in Yorkshire and Humber, including Leeds Children's Hospital, Sheffield Children's, and nearly 70 care homes. The integration of TytoCare into the NHS' current virtual care offerings will allow clinicians to diagnose and treat patients remotely with in-depth, physical examinations during video visits and the device will also be used offline for asynchronous exams.

Key Points: 
  • The expansion is currently being implemented in various use cases, including care homes, remote patient monitoring, post-discharge care, paediatric virtual wards, and respiratory care.
  • "We are honoured that the NHS has chosen to implement our telehealth solution across NHS trusts," said Dedi Gilad, CEO and Co-Founder of TytoCare.
  • We look forward to continuing our work with the NHS to expand its incredible telehealth programs across the UK."
  • "We're thrilled to provide the TytoCare solution to 14 different trusts, across 26 projects, ensuring patients are getting the best possible care.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) selects Commonwealth Informatics Inc to explore the use of AI and Machine Learning across Safety Surveillance

Monday, September 13, 2021 - 1:45pm

Geoff Gordon, Commonwealth President and Founder, said"We are extremely proud to partner with the MHRA on this transformative project to bring real tangible improvements to safety surveillance.

Key Points: 
  • Geoff Gordon, Commonwealth President and Founder, said"We are extremely proud to partner with the MHRA on this transformative project to bring real tangible improvements to safety surveillance.
  • Commonwealth Informatics is a technology and services company with industry expertise in medical product safety and public health surveillance.
  • Commonwealth is an independently-operated subsidiary of Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation.
  • Learn more about the innovative products and services that are helping to improve the speed and accuracy of pharmacovigilance evidence generation at https://www.commoninf.com.

Holmusk's MaST Selected to Inaugural NHSX Digital Playbook on Mental Health

Wednesday, July 28, 2021 - 8:00am

LONDON, July 28, 2021 /PRNewswire/ --MaST, a leading mental health decision support tool in the UK, has been recognised in the inaugural NHSX Digital Playbook on mental health.

Key Points: 
  • LONDON, July 28, 2021 /PRNewswire/ --MaST, a leading mental health decision support tool in the UK, has been recognised in the inaugural NHSX Digital Playbook on mental health.
  • MaST uses predictive analytics to help NHS mental health staff make more informed decisions about the resources they use to provide safer and higher quality care.
  • This news follows another recognition by NHSX, which selected MaST to be one of the few Digital Technology Assessment Criteria (DTAC) recognised products as part of the new criteria for digital health technologies entering the NHS and social care.
  • MaST was founded in 2015 and uses health records data to gain valuable insights into mental health in the UK for use in clinical practice.

Digital Transformation Tops Hospitals’ Priorities, According to New Lumeon Research

Tuesday, June 29, 2021 - 12:00pm

Lumeon , the leader in care journey orchestration, today announced new data that uncovers the top priorities for digital transformation among leaders of U.S. hospitals, integrated delivery networks, and ambulatory care centers.

Key Points: 
  • Lumeon , the leader in care journey orchestration, today announced new data that uncovers the top priorities for digital transformation among leaders of U.S. hospitals, integrated delivery networks, and ambulatory care centers.
  • The research found that in 2021, digital transformation has become the major priority for U.S. healthcare leaders.
  • Improving patient access is the top digital transformation goal for 59% of providers questioned in the survey.
  • View the full report here to learn more about the digital transformation priorities and challenges facing U.S. healthcare providers in the coming years.

Ibex Medical Analytics Wins UK Award to Accelerate Adoption of AI-Powered Cancer Detection in the NHS

Tuesday, September 22, 2020 - 2:00pm

In the UK, nearly 100,000 men undergo prostate biopsies every year, a number expected to double in the next ten years.

Key Points: 
  • In the UK, nearly 100,000 men undergo prostate biopsies every year, a number expected to double in the next ten years.
  • Coupled with a global shortage of pathologists, the increasing workloads lead to delayed diagnosis and treatment for cancer as well as concerns over misdiagnoses.
  • As part of the award program, Ibex's Galen Prostate solution will be used in 6 NHS hospitals in the largest ever government funded multi-site deployment in the UK.
  • "We are honored to receive this award from the NIHR and NHSx," said Daphna Laifenfeld, PhD, Ibex Chief Scientific Officer.

Committee questions NHS about healthcare data to assist older people

Thursday, February 20, 2020 - 12:03am

The Committee will ask the Head of NHSX and officials from NHS Digital how the NHS uses the vast amount of data that it gathers, in order to plan healthcare services.

Key Points: 
  • The Committee will ask the Head of NHSX and officials from NHS Digital how the NHS uses the vast amount of data that it gathers, in order to plan healthcare services.
  • The Committee will also hear from the National Data Guardian about the safeguards that govern the use of this patient data.
  • To what extent is healthcare data from the NHS shared outside the NHS, and what are the challenges associated with this?
  • data from medical monitoring devices and from commercial wearables) and data collected in the NHS?

Committee questions NHS about healthcare data to assist older people

Thursday, February 20, 2020 - 12:03am

The Committee will ask the Head of NHSX and officials from NHS Digital how the NHS uses the vast amount of data that it gathers, in order to plan healthcare services.

Key Points: 
  • The Committee will ask the Head of NHSX and officials from NHS Digital how the NHS uses the vast amount of data that it gathers, in order to plan healthcare services.
  • The Committee will also hear from the National Data Guardian about the safeguards that govern the use of this patient data.
  • To what extent is healthcare data from the NHS shared outside the NHS, and what are the challenges associated with this?
  • data from medical monitoring devices and from commercial wearables) and data collected in the NHS?